#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

Alternating hemiplegia of childhood Myotonic dystrophy Hereditary angioedema with C1 esterase inhibitor deficiency Mucous membrane pemphigoid Congenital aplastic anaemia Rett syndrome Acute promyelocytic leukaemia Epstein-Barr virus associated lymphoproliferative disorder Infantile spasms Extra-osseous Ewing's sarcoma recurrent Acute lymphocytic leukaemia recurrent Lennox-Gastaut syndrome Hypomagnesaemia Multiple system atrophy Small cell lung cancer More trials…

Learn about Rare Diseases

Haemophilia B without inhibitors Retinoblastoma – Diagnostics Prader-Willi syndrome – Basic Information Osteosarcoma metastatic – Trials in Disease Primary hyperoxaluria – Treatment Small intestine leiomyosarcoma – Diagnostics Bronchiolitis obliterans syndrome Chondrosarcoma – Diagnostics Choroid melanoma – Treatment Netherton’s syndrome – Diagnostics More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

Mk-1088 CHOLINE ALFOSCERATE Phenprocoumon Nitrogen Temocillin Sodium YL201 Hdp-101 Carisbamate SOFOSBUVIR Phentermine Inupadenant Hydrochloride Pegipanermin SILYMARIN Riluzole Chlorpromazine Necvax-Neo1 Acou085 Menotrophin Ambroxol Hydrochloride Tebipenem Pivoxil Hydrobromide More therapies…

Learn about Your Condition

Neck pain Subdural haematoma Cirrhosis alcoholic Myocarditis post infection Rhabdoid tumour of the kidney Hypotonia Meniscus injury Endometrial stromal sarcoma Urticaria chronic Hypochromic anaemia Trigeminal neuralgia Clostridium difficile colitis Nephrotic syndrome Ovarian cancer Breast proliferative changes More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe

🇦🇹 Austria

🇭🇷 Croatia

🇨🇿 Czech Republic

🇩🇰 Denmark

🇪🇪 Estonia

🇫🇮 Finland

🇫🇷 France

🇩🇪 Germany

🇮🇸 Iceland

🇮🇹 Italy

🇱🇻 Latvia

🇱🇹 Lithuania

🇳🇱 Netherlands

🇳🇴 Norway

🇵🇱 Poland

🇵🇹 Portugal

🇷🇴 Romania

🇸🇰 Slovakia

🇸🇮 Slovenia

🇪🇸 Spain

🇸🇪 Sweden

Chronic lymphocytic leukaemia

Long-Term Safety Study of Venetoclax for Patients with Chronic Lymphocytic Leukemia, Non-Hodgkin’s Lymphoma, Multiple Myeloma, or Acute Leukemia

Not recruiting

3 1 1
Investigated Diseases:
Investigated Drugs:
- Venetoclax
+1
Study on Stopping and Restarting Acalabrutinib in Elderly Patients with Untreated Chronic Lymphocytic Leukemia (CLL)

Not recruiting

2 1 1 1
Investigated Diseases:
- B-cell small lymphocytic lymphoma
- Chronic lymphocytic leukaemia
Investigated Drugs:
- Acalabrutinib
Study on the Risk of Tumor Lysis Syndrome in Adults with Untreated Chronic Lymphocytic Leukemia Using Venetoclax, Obinutuzumab, or Acalabrutinib

Not recruiting

4 1 1 1
Investigated Diseases:
- Chronic lymphocytic leukaemia
Investigated Drugs:

1 … 11 12 13

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

Chronic lymphocytic leukaemia

Long-Term Safety Study of Venetoclax for Patients with Chronic Lymphocytic Leukemia, Non-Hodgkin’s Lymphoma, Multiple Myeloma, or Acute Leukemia

Study on Stopping and Restarting Acalabrutinib in Elderly Patients with Untreated Chronic Lymphocytic Leukemia (CLL)

Study on the Risk of Tumor Lysis Syndrome in Adults with Untreated Chronic Lymphocytic Leukemia Using Venetoclax, Obinutuzumab, or Acalabrutinib

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies